ArticleJournal for immunotherapy of cancer2019

Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.

Valentina Bonanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.